epirubicin has been researched along with Leukopenia in 81 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (25.93) | 18.7374 |
| 1990's | 29 (35.80) | 18.2507 |
| 2000's | 17 (20.99) | 29.6817 |
| 2010's | 12 (14.81) | 24.3611 |
| 2020's | 2 (2.47) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LS; Guo, X; Hou, YY; Liu, WS; Lu, WQ; Luo, RK; Wang, ZM; You, Y; Zhang, CL; Zhang, Y; Zhou, YH; Zhuang, RY | 1 |
| Chu, M; Huang, TT; Lin, YT; Pei, J; Wang, J; Wang, YD; Yao, YF; Zhang, YY; Zheng, XY; Zhu, YL | 1 |
| Chi, Y; Song, Y; Wang, J; Yang, L; Zhou, A | 1 |
| Arnould, L; Bonnetain, F; Borg, C; Cleau, D; El Gani, M; Fein, F; Fratté, S; Ghiringhelli, F; Jacquin, M; Jary, M; Kim, S; Lamfichekh, N; Lassabe, C; Mathieu, P; Nerich, V; Nguyen, T; Paget-Bailly, S; Valmary-Degano, S | 1 |
| Chiba, T; Kanai, F; Kanogawa, N; Motoyama, T; Ogasawara, S; Ooka, Y; Saito, T; Suzuki, E; Tawada, A; Yokosuka, O; Yoshikawa, M | 1 |
| Berdel, WE; Brehler, AC; Hartmann, W; Kerkhoff, A; Kessler, T; Lenze, F; Palmes, D; Schliemann, C; Senninger, N; Ullerich, H; Wiebe, S | 1 |
| Goense, L; Haj Mohammad, N; Meijer, GJ; Mook, S; Ruurda, JP; van der Horst, S; van der Sluis, PC; van Hillegersberg, R; van Rossum, PSN; van Vulpen, M | 1 |
| Barrett-Lee, P; Bartlett, JM; Bliss, JM; Bloomfield, D; Cameron, D; Canney, P; Coleman, R; Dowsett, M; Earl, H; Ellis, I; Ellis, P; Hall, E; Hopwood, P; Johnson, L; Johnston, S; O'Reilly, S; Peckitt, C; Poole, C; Smith, I; Twelves, C; Verrill, M; Wardley, A; Yarnold, J | 1 |
| Ahlgren, J; Andersen, J; Andersson, M; Bergh, J; Bjerre, K; Blomquist, C; Lidbrink, E; Lindman, H; Mouridsen, H; Rosendahl, M | 1 |
| Feng, M; Qiu, F; Xiang, XJ; Xiong, JP; Yu, F; Zhan, ZY; Zhang, L | 1 |
| Conrad, B; Forstbauer, H; Koehne, CH; Kremers, S; Linder, M; Loibl, S; Moebus, V; Mueller, V; Nekljudova, V; von Minckwitz, G | 1 |
| Balslev, E; Bernsdorf, M; Ejlertsen, B; Ingvar, C; Jakobsen, EH; Jörgensen, L; Kimper-Karl, ML; Kroman, N; Saetersdal, A; Tuxen, MK | 1 |
| Ahlgren, J; Andersson, M; Bengtsson, NO; Bergh, J; Bjerre, K; Blomqvist, C; Edlund, P; Holmberg, SB; Jakobsen, E; Lindman, H; Mouridsen, H; Møller, S | 1 |
| Honda, J; Kamatani, N; Kubo, M; Nakamura, Y; Sasa, M; Srinivasan, Y; Takahashi, A; Uno, S; Zembutsu, H | 1 |
| Ding, Q; He, Z; Liang, X; Liu, X; Wang, S; Zha, X; Zhou, W | 1 |
| Fan, Y; Li, Q; Ma, F; Wang, JY; Wang, WM; Xu, BH; Yuan, P; Zhang, P | 1 |
| Barni, S; Berardi, R; Beretta, GD; Cascinu, S; Catalano, V; D'Angelo, A; Franciosi, V; Graziano, F; Labianca, R; Martignoni, G; Salvagni, S; Scartozzi, M; Silva, RR; Zaniboni, A | 1 |
| Abrial, CJ; Amat, S; Chollet, PJ; Curé, HD; Feillel, VA; Ferrière, JP; Kwiatkowski, FG; Lebouëdec, G; Mouret-Reynier, MA; Penault-Llorca, FM | 1 |
| Byun, JH; Choi, MG; Chung, IS; Hong, YS; Kang, JH; Kim, KW; Lee, KS; Lee, MA; Moon, DH; Park, SY; Shim, BY; Woo, IS | 1 |
| Blohmer, JU; Elling, D; Heinrich, G; Kohls, A; Kümmel, S; Lichtenegger, W; Paepke, S; Schwarz, M; Thomas, A; Wetzel, A | 1 |
| Basić, I; Orsolić, N | 1 |
| Koulentianos, E; Polyzos, A; Sfikakis, P; Tzianoumis, L | 1 |
| Hamada, K; Kubota, K; Mori, S; Nakagawa, A; Suzuki, N; Tagaya, N | 1 |
| Dohden, K; Hattori, M; Hayashi, H; Hosokawa, O; Kaizaki, Y; Kiya, T; Morishita, M; Morita, M; Ohta, K | 1 |
| Cheng, B; Liu, K; Qiu, DB; Wang, GB | 1 |
| Angelucci, E; Baldini, L; Federico, M; Gavarotti, P; Gobbi, P; Iannitto, E; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Orsucci, L; Pavone, V; Ricardi, U; Ucci, G | 1 |
| Adjei, AA; Aubry, MC; Delaune, R; Foster, NR; Kardinal, CG; Maurer, MJ; Nikcevich, DA; Northfelt, DW; Okuno, SH; Rowland, KM; Sloan, JA; Soori, GS | 1 |
| Hao, XM; Hui, R; Zhang, J; Zhang, M | 1 |
| Casper, ES; Gralla, RJ; Heelan, RT; Kalman, LA; Kelsen, DP; Kris, MG; Wittes, RE | 1 |
| Ahmed, T; Benedetto, P; Needles, B; Watson, RC; Yagoda, A | 1 |
| Grunenberg, B; Krischke, W; Niederle, N; Schmidt, CG; Schütte, J; Seeber, S | 1 |
| Bellanova, B; Camaggi, CM; Giovannini, M; Martini, A; Martoni, A; Monetti, N; Pannuti, F; Rossini, G; Tarquinii, M; Tomasi, L | 1 |
| Bramwell, V; Bruntsch, U; Cavalli, F; Decoster, G; Dombernowsky, P; Høst, H; Renard, G; Rozencweig, M; ten Bokkel Huinink, W; Van Glabbeke, M | 1 |
| Adachi, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Nakada, K; Ogawa, M; Okada, Y; Tada, A; Usui, N | 1 |
| Fujimoto, T; Kimura, K; Masaoka, T; Niitani, H; Saito, T; Tamura, K; Toki, H; Tominaga, T; Wakui, A | 1 |
| Kemeny, N; Michaelson, R; Young, C | 1 |
| Algeri, R; Guarnieri, A; Neri, B; Pacini, P; Rinaldini, M; Tucci, E; Valzelli, S | 1 |
| Bafaloukos, D; Beer, M; Fahantidis, E; Fountzilas, G; Giannakakis, T; Katsohis, C; Klouvas, G; Kosmidis, P; Pavlidis, N; Skarlos, D | 1 |
| Amato, C; Callari, A; Cannata, G; Cipolla, C; Cusimano, MP; Garascia, C; Gebbia, N; Gebbia, V; Latteri, MA; Testa, A | 1 |
| Igawa, M; Kadena, H; Ueda, M; Usui, T | 1 |
| Fukuda, K; Kikkawa, N; Kobayashi, K; Mishima, H; Shin, E; Takatsuka, Y; Tono, T; Yagyuu, T | 1 |
| Akesson, M; Andersson, H; Friberg, LG; Horvath, G; Johansson, O; Westberg, R | 1 |
| Airoma, G; Bianco, AR; De Placido, S; Gridelli, C; Incoronato, P; Palazzolo, G; Pepe, R; Rossi, A | 1 |
| Antilli, A; Ardizzoni, A; Bruzzi, P; De Marinis, F; Mariani, GL; Pallotta, G; Pennucci, MC; Rosso, R; Rubagotti, A; Salvati, F | 1 |
| Buonadonna, A; Carbone, A; Crivellari, D; De Paoli, A; Foladore, S; Frustaci, S; Monfardini, S; Morassut, S; Sorio, R | 1 |
| Burghouts, JT; Conroy, T; de Graeff, A; Fickers, M; Lalisang, F; Paillot, B; Roelofs, EJ; Wagener, DJ; Wils, J | 1 |
| Blomqvist, C; Hietanen, P; Rissanen, P; Teerenhovi, L | 1 |
| Kikkawa, N; Shin, E; Takatsuka, Y | 1 |
| Fosså, SD; Heilo, A; Hernes, EH; Ogreid, P; Paus, E; Vaage, S | 1 |
| Adachi, I; Kanda, K; Murai, H; Ogita, M; Saeki, T; Sano, M; Sasaki, Y; Shimoyama, M; Tabei, T; Takashima, S; Watanabe, T | 1 |
| Cardarelli, N; Cascinu, S; Catalano, G; Giordani, P; Graziano, F; Marcellini, M; Menichetti, ET | 1 |
| Badzio, A; Jassem, J; Jereczek-Fossa, B; Karnicka-Młodkowska, H; Kowal, E; Krawczyk, K; Malak, K; Moś-Antkowaik, R; Pilarska-Machowicz, A; Radzikowska, E | 1 |
| Arisawa, J; Hosoki, T; Inoue, Y; Masuzawa, M; Monden, M; Monden, T; Nakamura, H; Nakao, N; Ohi, H; Ohsaki, Y; Sakon, M; Seki, K; Shimizu, T; Todo, A; Tomono, N; Yayoi, E | 1 |
| de Vries, EG; Hospers, GA; Mulder, NH; Schröder, CP; Sleijfer, DT; van der Graaf, WT; Willemse, PH | 1 |
| Forni, M; Kobierska, A; Piccart, MJ; ten Bokkel Huinink, WW; van der Burg, ME; van der Putten, E; Vermorken, JB | 1 |
| Bláha, M; Filip, S; Mericka, P; Odrázka, K; Vávrová, J | 1 |
| Bláha, M; Filip, S; Maricka, P; Medková, V; Stránský, P; Vanásek, J; Vavrová, J | 1 |
| Hosaka, M; Ikeda, I; Kawakami, S; Kubota, Y; Masuda, M; Noguchi, S; Ohuchi, H; Saito, K; Takase, K; Yao, M | 1 |
| Arland, M; Bartsch, R; Florschütz, A; Franke, A; Höffkes, HG; Kahl, C; Lange, S; Leuner, S | 1 |
| Berendsen, HH; Piers, DA; Postmus, PE; Riva, A; Smeets, J; Smit, EF | 1 |
| Gatzemeier, U; Hossfeld, DK; Laumen, R; Lenaz, L; Neuhauss, R; Reck, M; von Pawel, J | 1 |
| Piers, DA; Postmus, PE; Smit, EF | 1 |
| Delozier, T; Vernhes, JC | 1 |
| Kouri, MO; Pyrhönen, SO | 1 |
| Aikawa, T; Kobayashi, T; Kotsuma, Y; Takatsuka, Y; Yayoi, E | 1 |
| Aikawa, T; Furukawa, J; Kaji, M; Kobayashi, T; Kotsuma, Y; Maeura, Y; Takatsuka, Y; Yayoi, E | 1 |
| Armas, A; Asins Codoner, J; Calero, F; Iglesias, J; Jimeno, J; Mendana, J; Murillo, F; Rementería, A; Rodríguez-Escudero, F; Ugalde, F | 1 |
| Herweijer, H; Nooter, K; Oosterom, R; Planting, AS; Seynaeve, C; Stoter, G; van der Burg, ME; Verweij, J | 1 |
| Hall, RR; Macneil, HF; Neal, DE; Roberts, JT | 1 |
| Caliceti, U; Guaraldi, M; Martoni, A; Occhiuzzi, L; Pannuti, F; Romagnoli, D; Rossi, AP | 1 |
| Calciati, A; de Pauw, M; Fosså, SD; Pavone-Macaluso, M; Roozendaal, KJ; Splinter, T; Sylvester, R; Veenhof, KH | 1 |
| Asaishi, K; Hayasaka, H; Mikami, T; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Sato, H; Toda, K; Watanabe, Y | 1 |
| Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Mizunuma, N; Mukaiyama, T; Ogawa, M; Shinagawa, K; Tabata, M | 1 |
| Sakata, Y; Yoshida, Y | 1 |
| Abe, O; Enomoto, K; Iino, Y; Ikeda, T; Izuo, M; Kitamura, M; Nomura, Y; Taguchi, T; Tamura, K; Tominaga, T | 1 |
| Hayakawa, M; Hayashi, T; Kano, H; Kimura, K; Morise, K; Nagano, I; Nakai, T; Sakakibara, K; Suga, S; Yokoyama, Y | 1 |
| Chiba, Y; Hirota, Y; Kobayashi, T; Masaoka, T; Sampi, K; Shibata, H; Shirakawa, S; Tamura, K; Toki, H; Yoshida, Y | 1 |
| Akaza, H; Isaka, S; Ishikawa, H; Koiso, K; Koyanagi, T; Maru, A; Niijima, T; Sakashita, S; Shimazaki, J; Uchida, K | 1 |
| Abate, G; Basso, A; Comella, P; Di Pietro, N; Ganzina, F; Pergola, M; Salvatore, M; Silvestro, P; Zarrilli, D | 1 |
| Bruntsch, U; Cavalli, F; Hansen, HH; Holdener, EE; Høst, H; Pinedo, HM; Renard, J; Rozencweig, M | 1 |
| Di Lauro, L; Di Pietro, N; Ganzina, F; Lopez, M; Papaldo, P; Perno, CF | 1 |
1 review(s) available for epirubicin and Leukopenia
| Article | Year |
|---|---|
[Comparative study of adriamycin, epirubicin and mitoxantrone in cancer of the breast. Review of the literature].
Topics: Alopecia; Doxorubicin; Epirubicin; Heart; Humans; Leukopenia; Mitoxantrone; Nausea; Randomized Controlled Trials as Topic | 1991 |
46 trial(s) available for epirubicin and Leukopenia
| Article | Year |
|---|---|
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial.
Topics: Adolescent; Anemia; Epirubicin; Humans; Leukopenia; Prospective Studies; Quinolines; Sarcoma; Soft Tissue Neoplasms | 2022 |
Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Cohort Studies; Drug Monitoring; Epirubicin; Esophageal Neoplasms; Esophagus; Feasibility Studies; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pilot Projects; Severity of Illness Index; Stomach; Stomach Neoplasms; Survival Analysis | 2014 |
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Belgium; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Early Diagnosis; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lethargy; Leukopenia; Middle Aged; Neutropenia; Proportional Hazards Models; Receptors, Estrogen; Taxoids; Treatment Outcome; United Kingdom | 2009 |
The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study.
Topics: Adult; Age Distribution; Age Factors; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Leukocyte Count; Leukopenia; Menstrual Cycle; Middle Aged; Primary Ovarian Insufficiency | 2009 |
A phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) as first-line chemotherapy in advanced gastric cancer: a Chinese single-center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Capecitabine; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Treatment Outcome | 2010 |
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Middle Aged; Neutropenia; Paclitaxel; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Time Factors; Young Adult | 2011 |
Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Fever; Gefitinib; Humans; Leukopenia; Middle Aged; Neoadjuvant Therapy; Neutropenia; Quinazolines; Receptors, Estrogen; Research Design; Treatment Outcome; Tumor Burden | 2011 |
Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Feasibility Studies; Female; Fluorouracil; Humans; Individuality; Leukopenia; Mastectomy; Maximum Tolerated Dose; Middle Aged; Precision Medicine; Scandinavian and Nordic Countries; Severity of Illness Index; Treatment Outcome | 2011 |
[Docetaxel plus carboplatin versus EC-T as adjuvant chemotherapy for triple-negative breast cancer: safety data from a phase III randomized open-label trial].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Staging; Neutropenia; Premenopause; Radiotherapy, Adjuvant; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Vomiting | 2012 |
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Filgrastim; Fluorouracil; Glutathione; Granulocyte Colony-Stimulating Factor; Humans; Leucovorin; Leukopenia; Levoleucovorin; Male; Middle Aged; Neoadjuvant Therapy; Recombinant Proteins; Stomach Neoplasms; Thrombocytopenia; Treatment Outcome | 2004 |
Neoadjuvant FEC 100 for operable breast cancer: eight-year experience at Centre Jean Perrin.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Retrospective Studies; Treatment Outcome | 2004 |
A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Combinations; Epirubicin; Female; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: a phase II study.
Topics: Adult; Aged; Anemia; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymph Node Excision; Middle Aged; Prospective Studies; Remission Induction; Skin; Taxoids | 2005 |
[Clinical comparison of GC regimen (gemcitabine and cisplatin) versus FEC regimen (fluorouracil, epirubicin, and cyclophosphamide) as neoadjuvant chemotherapy for breast cancer].
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Deoxycytidine; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Middle Aged; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Remission Induction | 2007 |
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Heart Diseases; Hodgkin Disease; Humans; Infections; Italy; Leukopenia; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Severity of Illness Index; Treatment Outcome; Vinblastine | 2008 |
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Injections, Intravenous; Leukopenia; Male; Mesothelioma; Middle Aged; Neutropenia; Pleural Neoplasms; Quality of Life; Remission Induction; Ribonucleotide Reductases; Survival Rate; Thrombocytopenia; Treatment Outcome | 2008 |
[Comparison of tolerance and toxicity of CEF-100 regimen versus CEF-60 regimen as adjuvant therapy for breast cancer].
Topics: Adult; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Middle Aged; Neutropenia; Vomiting | 2007 |
Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Carubicin; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Female; Follow-Up Studies; Heart Diseases; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Metastasis; Random Allocation; Vomiting | 1984 |
Combination chemotherapy with epirubicin and mitomycin C as first-line treatment in advanced breast cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Mitomycin; Neoplasm Metastasis; Palliative Care; Time Factors | 1994 |
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Middle Aged; Recombinant Proteins | 1995 |
A phase I-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Leucovorin; Leukopenia; Middle Aged; Recombinant Proteins; Treatment Outcome | 1994 |
[Neoadjuvant intraarterial chemotherapy with dose intensification in locally advanced breast cancer].
Topics: Alopecia; Antibiotics, Antineoplastic; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Middle Aged; Prospective Studies | 1995 |
Carboplatin in combination with epirubicin and cyclophosphamide in patients with advanced ovarian cancer. A phase II study.
Topics: Adult; Aged; Ambulatory Care; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cyclophosphamide; Disease Progression; Epirubicin; Female; Follow-Up Studies; Humans; Laparotomy; Leukopenia; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Remission Induction; Reoperation; Survival Rate; Thrombocytopenia; Vomiting | 1995 |
Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vinorelbine | 1993 |
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Italy; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Rate; Thrombocytopenia | 1993 |
Epirubicin and ifosfamide in advanced soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Feasibility Studies; Female; Humans; Ifosfamide; Italy; Leukopenia; Male; Middle Aged; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Survival Rate | 1993 |
Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Thrombocytopenia | 1993 |
[A clinical trial of neoadjuvant intraarterial chemotherapy for the treatment of locally advanced breast cancer].
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intra-Arterial; Leukopenia; Middle Aged; Survival Rate | 1996 |
Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Estramustine; Gastrointestinal Diseases; Gonadotropin-Releasing Hormone; Heart Diseases; Humans; Leukopenia; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Thrombocytopenia | 1997 |
A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neutropenia; Prospective Studies; Receptors, Estrogen; Recombinant Proteins; Survival Rate; Thrombocytopenia | 1997 |
Phase II study of paclitaxel in pretreated advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Stomach Neoplasms; Survival Analysis; Thrombocytopenia; Time Factors | 1998 |
Does chemotherapy-induced leukopenia predict a response in small-cell lung cancer?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Leukocyte Count; Leukopenia; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Treatment Outcome; Vincristine | 1998 |
[Results of clinical study with epirubicin hydrochloride injectable solution in hepatoma].
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Administration Schedule; Epirubicin; Fever; Hepatic Artery; Humans; Injections, Intra-Arterial; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1998 |
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ciprofloxacin; Costs and Cost Analysis; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Female; Fever; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Length of Stay; Leukopenia; Methotrexate; Middle Aged; Neoplasm Metastasis; Netherlands; Prospective Studies; Recombinant Proteins | 1999 |
Phase I study of high-dose epirubicin in platinum-pretreated patients with ovarian carcinoma.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Ovarian Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Leukapheresis; Leukopenia; Middle Aged; Platelet Transfusion; Salvage Therapy; Stem Cells; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome | 2000 |
Intensive cyclic chemotherapy with unprocessed whole blood support in advanced breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Chemotherapy, Adjuvant; Cryopreservation; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Leukopenia; Middle Aged; Thrombocytopenia | 2001 |
Ifosamide, epirubicin and granulocyte colony-stimulating factor: a regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Therapeutic Equivalency | 2001 |
A phase II study of high dose epirubicin in unresectable non small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Epirubicin; Female; Hemoglobins; Humans; Infusions, Intravenous; Leukocyte Count; Leukopenia; Lung Neoplasms; Male; Middle Aged; Platelet Count; Ventricular Function, Left | 1992 |
Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Recurrence; Thrombocytopenia; Time Factors; Vincristine | 1992 |
Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Epirubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia | 1992 |
Phase II study of epirubicin sequential methotrexate and 5-fluorouracil for advanced colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms | 1992 |
[A prospective randomized study of intra-arterial infusion chemotherapy in the treatment of advanced breast cancer].
Topics: Alopecia; Breast Neoplasms; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Middle Aged; Postoperative Care; Prospective Studies; Survival Rate | 1992 |
Epirubicin: clinical toxicity during the phase II program in endometrial and cervical cancer.
Topics: Adult; Aged; Alopecia; Drug Evaluation; Endometrial Neoplasms; Epirubicin; Female; Heart; Humans; Leukopenia; Middle Aged; Spain; Uterine Cervical Neoplasms; Vomiting | 1992 |
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.
Topics: Adult; Aged; Colorectal Neoplasms; Cyclosporins; Drug Resistance; Epirubicin; Female; Flow Cytometry; Humans; In Vitro Techniques; Leukopenia; Male; Middle Aged | 1991 |
[Phase II study of epirubicin in inoperable or recurrent gastric cancer].
Topics: Adult; Aged; Anemia; Anorexia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Thrombocytopenia | 1986 |
34 other study(ies) available for epirubicin and Leukopenia
| Article | Year |
|---|---|
[Therapeutic Effect of Spleen Low Molecular Weight Extracts on Leukopenia Caused by Epirubicin in Mice and Its Mechanism].
Topics: Animals; Epirubicin; Granulocyte Colony-Stimulating Factor; Leukocyte Count; Leukopenia; Mice; Molecular Weight; Plant Extracts; Recombinant Proteins; Spleen | 2021 |
[Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Thrombocytopenia; Urinary Bladder Neoplasms; Urothelium | 2014 |
Transarterial chemoembolization with miriplatin plus epirubicin in patients with hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Anemia; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Epirubicin; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Retrospective Studies; Treatment Outcome | 2015 |
Perioperative chemotherapy in gastroesophageal cancer. A retrospective monocenter evaluation of 42 cases.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Diarrhea; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Perioperative Care; Retrospective Studies; Stomach; Stomach Neoplasms; Survival Analysis | 2015 |
Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Disease Progression; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Neoadjuvant Therapy; Netherlands; Paclitaxel; Propensity Score; Thromboembolism | 2017 |
Genome-wide association study of epirubicin-induced leukopenia in Japanese patients.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Case-Control Studies; Cell Cycle Proteins; Cytoskeletal Proteins; Endometrial Neoplasms; Epirubicin; Female; Genome-Wide Association Study; Humans; Japan; Leukopenia; Linkage Disequilibrium; Liver Neoplasms; Male; Neoplasms; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Prognosis; Risk Factors | 2011 |
The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Asian People; Breast Neoplasms; China; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Premenopause; Retrospective Studies; Taxoids | 2012 |
Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood Cell Count; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Epirubicin; Female; Gamma Rays; Hematopoiesis; Injections, Intraperitoneal; Leukopenia; Lung Neoplasms; Macrophages, Peritoneal; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Propolis; Radiation-Protective Agents; Solubility; Time Factors | 2005 |
Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Biopsy; Dose-Response Relationship, Drug; Epirubicin; Humans; Leukopenia; Male; Mitomycin; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neutropenia; Treatment Outcome | 1989 |
[Pilot study of primary systemic chemotherapy with docetaxel (DOC), epirubicin (EPI) and capecitabine (Xeloda) in patients with advanced breast cancer].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neutropenia; Pilot Projects; Taxoids | 2006 |
[Clinical examination of safety and effectiveness of primary chemotherapy with CEF followed by docetaxel in preoperative breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Breast Neoplasms, Male; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Male; Mastectomy, Segmental; Middle Aged; Nausea; Taxoids; Vomiting, Anticipatory | 2006 |
Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.
Topics: Adult; Aged; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Middle Aged | 1983 |
Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Thrombocytopenia | 1983 |
4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
Topics: Adult; Aged; Alopecia; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Testicular Neoplasms; Thrombocytopenia | 1984 |
A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors.
Topics: Adult; Aged; Anemia; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Stroke Volume; Thrombocytopenia | 1984 |
[A phase I trial of 4'-epiadriamycin].
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Thrombocytopenia | 1984 |
[A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
Topics: Anorexia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Humans; Leukopenia; Nausea; Neoplasms | 1984 |
Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Fatigue; Humans; Leukopenia; Middle Aged; Nausea; Rectal Neoplasms; Stereoisomerism; Vomiting | 1982 |
M-VEC (methotrexate, vinblastine, 4'-epirubicin and cisplatin) combined with glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the treatment of transitional cell carcinoma of urothelium: reduction in toxicity produced by r
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Glycosylation; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Recombinant Proteins; Survival Analysis; Thrombocytopenia; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Epirubicin; Female; Humans; Leukopenia; Remission Induction; Vinblastine; Vinorelbine | 1995 |
[Study of neoadjuvant chemotherapy for invasive bladder cancer with MEC (methotrexate, epirubicin, cisplatin) therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Prognosis; Survival Analysis; Thrombocytopenia; Urinary Bladder Neoplasms | 2001 |
[Intra-arterial infusion chemotherapy in the treatment of advanced breast cancer--doxorubicin versus epirubicin].
Topics: Alopecia; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Subclavian Artery; Survival Rate | 1992 |
Systemic chemotherapy for urothelial cancer in patients with ureteric obstruction.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Creatinine; Doxorubicin; Epirubicin; Humans; Leukopenia; Methotrexate; Middle Aged; Neoplasm Staging; Ureteral Obstruction; Urinary Bladder Neoplasms; Vinblastine | 1991 |
Treatment of advanced head and neck tumors with PEV-B regimen: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; Epirubicin; Etoposide; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Pilot Projects | 1988 |
A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Thrombocytopenia; Urinary Bladder Neoplasms | 1989 |
[Intra-arterial infusion chemotherapy of advanced breast cancer--effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin].
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Lymphatic Metastasis; Remission Induction; Thrombocytopenia | 1989 |
[Phase II study of combination chemotherapy with epirubicin, cyclophosphamide and ftorafur in metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Metastasis; Tegafur; Thrombocytopenia | 1988 |
[Phase II study of epirubicin on breast cancer: a cooperative group study].
Topics: Adult; Aged; Alopecia; Anorexia; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Middle Aged | 1986 |
[Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anemia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Heart; Humans; Leukopenia; Male; Middle Aged; Stomach Neoplasms | 1986 |
[A phase II study of epirubicin in malignant lymphoma].
Topics: Adult; Aged; Anemia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged | 1986 |
[Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
Topics: Aged; Anorexia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Hemoglobins; Humans; Infant; Infusions, Intravenous; Kidney Neoplasms; Kidney Pelvis; Leukopenia; Male; Middle Aged; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1986 |
Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclophosphamide; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Vincristine | 1987 |
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Rectal Neoplasms; Vomiting | 1985 |
Epirubicin in non-Hodgkin's lymphomas.
Topics: Adult; Aged; Alopecia; Doxorubicin; Epirubicin; Gastrointestinal Diseases; Humans; Leukopenia; Lymphoma; Middle Aged | 1985 |